Alembic Ltd

NSE: ALEMBICLTD · BSE: 506235 · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹104.99
Market cap: ₹2,696 Cr
Revenue (annual): ₹240.0 Cr
Net profit (annual): ₹317.4 Cr
P/E (TTM): 8.4×Sector 47.4×
Promoter holding: 70.88%+0.00% QoQ
FII holding: 1.25%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Buying 6 Financial Results 3 Other Announcement 2 Dividend 2 Board Meeting Date 2 Annual General Meeting 2 Debt & Borrowing 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 Apr 2026 16:35 IST NSE

Debt & Borrowing

Alembic Debt & Borrowing: ₹300 Cr

Alembic Pharmaceuticals Limited has announced record dates for two listed Commercial Papers totaling ₹300 Crore. The record dates are May 6, 2026, and May 28, 2026, for ISINs INE901L14CG4 and INE901L14CH2 respectively. This filing ensures administrative readiness for the upcoming maturity of these debt instruments.

Value: ₹300.0 Cr

Read the filing ↗